table of content
1 Introduction to Research & Analysis Reports
1.1 Immuno-oncology Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immuno-oncology Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immuno-oncology Therapy Overall Market Size
2.1 Global Immuno-oncology Therapy Market Size: 2022 VS 2035
2.2 Global Immuno-oncology Therapy Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immuno-oncology Therapy Players in Global Market
3.2 Top Global Immuno-oncology Therapy Companies Ranked by Revenue
3.3 Global Immuno-oncology Therapy Revenue by Companies
3.4 Top 3 and Top 5 Immuno-oncology Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Immuno-oncology Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immuno-oncology Therapy Players in Global Market
3.6.1 List of Global Tier 1 Immuno-oncology Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Immuno-oncology Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Immuno-oncology Therapy Market Size Markets, 2022 & 2035
4.1.2 Monoclonal Antibodies
4.1.3 Immune Checkpoint Inhibitors
4.1.4 Immune System Modulators
4.1.5 Cancer Vaccines
4.2 By Type - Global Immuno-oncology Therapy Revenue & Forecasts
4.2.1 By Type - Global Immuno-oncology Therapy Revenue, 2018-2023
4.2.2 By Type - Global Immuno-oncology Therapy Revenue, 2024-2035
4.2.3 By Type - Global Immuno-oncology Therapy Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immuno-oncology Therapy Market Size, 2022 & 2035
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Center
5.1.4 Others
5.2 By Application - Global Immuno-oncology Therapy Revenue & Forecasts
5.2.1 By Application - Global Immuno-oncology Therapy Revenue, 2018-2023
5.2.2 By Application - Global Immuno-oncology Therapy Revenue, 2024-2035
5.2.3 By Application - Global Immuno-oncology Therapy Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Immuno-oncology Therapy Market Size, 2022 & 2035
6.2 By Region - Global Immuno-oncology Therapy Revenue & Forecasts
6.2.1 By Region - Global Immuno-oncology Therapy Revenue, 2018-2023
6.2.2 By Region - Global Immuno-oncology Therapy Revenue, 2024-2035
6.2.3 By Region - Global Immuno-oncology Therapy Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Immuno-oncology Therapy Revenue, 2018-2035
6.3.2 US Immuno-oncology Therapy Market Size, 2018-2035
6.3.3 Canada Immuno-oncology Therapy Market Size, 2018-2035
6.3.4 Mexico Immuno-oncology Therapy Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Immuno-oncology Therapy Revenue, 2018-2035
6.4.2 Germany Immuno-oncology Therapy Market Size, 2018-2035
6.4.3 France Immuno-oncology Therapy Market Size, 2018-2035
6.4.4 U.K. Immuno-oncology Therapy Market Size, 2018-2035
6.4.5 Italy Immuno-oncology Therapy Market Size, 2018-2035
6.4.6 Russia Immuno-oncology Therapy Market Size, 2018-2035
6.4.7 Nordic Countries Immuno-oncology Therapy Market Size, 2018-2035
6.4.8 Benelux Immuno-oncology Therapy Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Immuno-oncology Therapy Revenue, 2018-2035
6.5.2 China Immuno-oncology Therapy Market Size, 2018-2035
6.5.3 Japan Immuno-oncology Therapy Market Size, 2018-2035
6.5.4 South Korea Immuno-oncology Therapy Market Size, 2018-2035
6.5.5 Southeast Asia Immuno-oncology Therapy Market Size, 2018-2035
6.5.6 India Immuno-oncology Therapy Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Immuno-oncology Therapy Revenue, 2018-2035
6.6.2 Brazil Immuno-oncology Therapy Market Size, 2018-2035
6.6.3 Argentina Immuno-oncology Therapy Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Immuno-oncology Therapy Revenue, 2018-2035
6.7.2 Turkey Immuno-oncology Therapy Market Size, 2018-2035
6.7.3 Israel Immuno-oncology Therapy Market Size, 2018-2035
6.7.4 Saudi Arabia Immuno-oncology Therapy Market Size, 2018-2035
6.7.5 UAE Immuno-oncology Therapy Market Size, 2018-2035
7 Immuno-oncology Therapy Companies Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Immuno-oncology Therapy Major Product Offerings
7.1.4 Amgen Immuno-oncology Therapy Revenue in Global Market (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Immuno-oncology Therapy Major Product Offerings
7.2.4 AstraZeneca Immuno-oncology Therapy Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Major Product Offerings
7.3.4 Bristol-Myers Squibb Immuno-oncology Therapy Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 Eli-Lilly
7.4.1 Eli-Lilly Company Summary
7.4.2 Eli-Lilly Business Overview
7.4.3 Eli-Lilly Immuno-oncology Therapy Major Product Offerings
7.4.4 Eli-Lilly Immuno-oncology Therapy Revenue in Global Market (2018-2023)
7.4.5 Eli-Lilly Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Immuno-oncology Therapy Major Product Offerings
7.5.4 Roche Immuno-oncology Therapy Revenue in Global Market (2018-2023)
7.5.5 Roche Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Immuno-oncology Therapy Major Product Offerings
7.6.4 GlaxoSmithKline Immuno-oncology Therapy Revenue in Global Market (2018-2023)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 Janssen Biotech
7.7.1 Janssen Biotech Company Summary
7.7.2 Janssen Biotech Business Overview
7.7.3 Janssen Biotech Immuno-oncology Therapy Major Product Offerings
7.7.4 Janssen Biotech Immuno-oncology Therapy Revenue in Global Market (2018-2023)
7.7.5 Janssen Biotech Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Immuno-oncology Therapy Major Product Offerings
7.8.4 Merck Immuno-oncology Therapy Revenue in Global Market (2018-2023)
7.8.5 Merck Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Immuno-oncology Therapy Major Product Offerings
7.9.4 Novartis Immuno-oncology Therapy Revenue in Global Market (2018-2023)
7.9.5 Novartis Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Immuno-oncology Therapy Major Product Offerings
7.10.4 Pfizer Immuno-oncology Therapy Revenue in Global Market (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 Sanofi
7.11.1 Sanofi Company Summary
7.11.2 Sanofi Business Overview
7.11.3 Sanofi Immuno-oncology Therapy Major Product Offerings
7.11.4 Sanofi Immuno-oncology Therapy Revenue in Global Market (2018-2023)
7.11.5 Sanofi Key News & Latest Developments
7.12 Spectrum Pharmaceuticals
7.12.1 Spectrum Pharmaceuticals Company Summary
7.12.2 Spectrum Pharmaceuticals Business Overview
7.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Major Product Offerings
7.12.4 Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue in Global Market (2018-2023)
7.12.5 Spectrum Pharmaceuticals Key News & Latest Developments
7.13 Takeda
7.13.1 Takeda Company Summary
7.13.2 Takeda Business Overview
7.13.3 Takeda Immuno-oncology Therapy Major Product Offerings
7.13.4 Takeda Immuno-oncology Therapy Revenue in Global Market (2018-2023)
7.13.5 Takeda Key News & Latest Developments
7.14 BioNTech SE
7.14.1 BioNTech SE Company Summary
7.14.2 BioNTech SE Business Overview
7.14.3 BioNTech SE Immuno-oncology Therapy Major Product Offerings
7.14.4 BioNTech SE Immuno-oncology Therapy Revenue in Global Market (2018-2023)
7.14.5 BioNTech SE Key News & Latest Developments
7.15 Allogene Therapeutics
7.15.1 Allogene Therapeutics Company Summary
7.15.2 Allogene Therapeutics Business Overview
7.15.3 Allogene Therapeutics Immuno-oncology Therapy Major Product Offerings
7.15.4 Allogene Therapeutics Immuno-oncology Therapy Revenue in Global Market (2018-2023)
7.15.5 Allogene Therapeutics Key News & Latest Developments
7.16 IMAB-I-Mab Biopharma Co., Ltd.
7.16.1 IMAB-I-Mab Biopharma Co., Ltd. Company Summary
7.16.2 IMAB-I-Mab Biopharma Co., Ltd. Business Overview
7.16.3 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Major Product Offerings
7.16.4 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Revenue in Global Market (2018-2023)
7.16.5 IMAB-I-Mab Biopharma Co., Ltd. Key News & Latest Developments
7.17 Arcus Biosciences
7.17.1 Arcus Biosciences Company Summary
7.17.2 Arcus Biosciences Business Overview
7.17.3 Arcus Biosciences Immuno-oncology Therapy Major Product Offerings
7.17.4 Arcus Biosciences Immuno-oncology Therapy Revenue in Global Market (2018-2023)
7.17.5 Arcus Biosciences Key News & Latest Developments
7.18 Gritstone Oncology
7.18.1 Gritstone Oncology Company Summary
7.18.2 Gritstone Oncology Business Overview
7.18.3 Gritstone Oncology Immuno-oncology Therapy Major Product Offerings
7.18.4 Gritstone Oncology Immuno-oncology Therapy Revenue in Global Market (2018-2023)
7.18.5 Gritstone Oncology Key News & Latest Developments
7.19 Autolus Therapeutics
7.19.1 Autolus Therapeutics Company Summary
7.19.2 Autolus Therapeutics Business Overview
7.19.3 Autolus Therapeutics Immuno-oncology Therapy Major Product Offerings
7.19.4 Autolus Therapeutics Immuno-oncology Therapy Revenue in Global Market (2018-2023)
7.19.5 Autolus Therapeutics Key News & Latest Developments
7.20 Rubius Therapeutics
7.20.1 Rubius Therapeutics Company Summary
7.20.2 Rubius Therapeutics Business Overview
7.20.3 Rubius Therapeutics Immuno-oncology Therapy Major Product Offerings
7.20.4 Rubius Therapeutics Immuno-oncology Therapy Revenue in Global Market (2018-2023)
7.20.5 Rubius Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
